For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
Scope of the Report:
This report focuses on the Cardiac Rhythm Management (CRM) Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing instances of heart failure and other cardiac disorders and rising sedentary lifestyle among the population are estimated to boost market growth through 2025.
The classification of Cardiac Rhythm Management Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2017 is about 49.1%. The ICD in 2017 is about 36.6%.
Cardiac Rhythm Management Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2017 is 42.8%. And the market share used bradycardia in 2018 is 39.9%.
North America region is the largest supplier of Cardiac Rhythm Management Device, with a production market share nearly 84.7% in 2017. Europe is the second largest supplier of Cardiac Rhythm Management Device Media, enjoying production market share nearly 12.4% in 2017.
North America is the largest consumption place, with a consumption market share nearly 51.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.3%, Cardiac Rhythm Management Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense among top 5. Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin) are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Cardiac Rhythm Management (CRM) Devices is expected to grow at a CAGR of roughly 4.6% over the next five years, will reach 13400 million US$ in 2023, from 10200 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- St. Jude Medical (Abbott)
- Boston Scientific
- LivaNova (Sorin)
- Lepu (Qinming Medical)
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Heart Failure
There are 15 Chapters to deeply display the global Cardiac Rhythm Management (CRM) Devices market.
Chapter 1, to describe Cardiac Rhythm Management (CRM) Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Rhythm Management (CRM) Devices, with sales, revenue, and price of Cardiac Rhythm Management (CRM) Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Rhythm Management (CRM) Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiac Rhythm Management (CRM) Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiac Rhythm Management (CRM) Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source